SignIn
Kerala Kaumudi Online
Friday, 24 September 2021 2.43 AM IST

Pfizer prevents asymptomatic Covid-19 and death: Study

vaccine

NEW YORK: Pharmaceutical companies -- Pfizer and BioNTech -- announced on Thursday morning that real-world evidence from the Israel Ministry of Health show that there have been "dramatically" fewer Covid-19 cases and deaths among people in Israel who have been fully vaccinated with the Pfizer/BioNTech vaccine compared with those who have been not vaccinated.


CNN citing Pfizer and BioNTech's announcement reported that the latest analysis from the Israel Ministry of Health shows that two weeks after the second dose, vaccine effectiveness was at least 97 per cent in preventing symptomatic disease, hospitalizations and death. The analysis also found that the vaccine effectiveness was 94 per cent in preventing asymptomatic Covid-19, where infections show no symptoms.


"We are extremely encouraged that the real-world effectiveness data coming from Israel are confirming the high efficacy demonstrated in our Phase 3 clinical trial and showing the significant impact of the vaccine in preventing severe disease and deaths due to COVID-19," said Luis Jodar, Senior Vice President & Chief Medical Officer, Pfizer Vaccines.


"The findings which suggest that the vaccine may also provide protection against asymptomatic SARS-CoV-2 infections are particularly meaningful as we look to disrupt the spread of the virus around the globe. Altogether, these data are critical to understanding the role of vaccination in combatting the pandemic and provide hope to other countries dealing with this devastating disease, which has now afflicted the world for more than a year."


SARS-CoV-2 is the name of the virus that causes Covid-19.

According to CNN, The announcement comes about two weeks after a study published in the New England Journal of Medicine finding that the risk of symptomatic Covid-19 - meaning people who were infected with the coronavirus and felt sick - decreased by 94 per cent among those who received two doses of the vaccine. Even before the second dose, the vaccine's effectiveness approached 60 per cent.


"This clearly demonstrates the power of the COVID-19 vaccine to fight this virus and encourages us to continue even more intensively with our vaccination campaign. We aim to achieve even higher uptake in people of all ages, which gives us hope of regaining normal economic and social function in the not so distant future," Yeheskel Levy, Israel Ministry of Health director, said in the announcement, as quoted by CNN.


"When we started our development last year in January, our aim was to make a difference for people worldwide and to help end this pandemic," Dr Ugur Sahin, co-founder and CEO of BioNTech, said in the announcement and added, "One year after the declaration of a pandemic by the WHO, we now see that we are on the right track to accomplish our goals."


Albert Bourla, CEO of Pfizer, said data from Israel that shows the Pfizer/BioNTech vaccine prevents asymptomatic infection and death is a message of hope one year on from the declaration of a pandemic.


"It is a great opportunity, I think, that on this day of the first anniversary of the declaration of a pandemic, we do have a message of hope," Bourla told CNBC as reported by CNN.


Bourla said that this is important for society, "because the asymptomatic carriers, the asymptomatic patients are the ones that they are spreading the disease mainly." "This is the first time that we are coming with a confirmation of a real-world evidence study of that magnitude," he said.

JOIN THE DISCUSSION
TAGS: PFIZER, PFIZER VACCINE, COVID-19
KERALA KAUMUDI EPAPER
TRENDING IN WORLD
X
Lorem ipsum dolor sit amet
consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
We respect your privacy. Your information is safe and will never be shared.